Cellmid Limited (ASX:CDY) announced that IP Australia has released a notice of allowance for the Australian Patent Application 2014361754 named "Method of treatment of Alopecia with Monoterpenoids. A notice of allowance for the same patent has been issued by Japanese Patent Office.
The Monoterpenoids Patent for alopecia protects a part of the technology that differentiates the évolis® therapeutic & anti-aging hair care ranges from other products
On 24 April 2020, CDY shares ended the day’s trade at $0.225, up 2.273% from the previous close.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.